Xuzhou Medical University
Clinical trials sponsored by Xuzhou Medical University, explained in plain language.
-
Engineered immune cells take on stubborn leukemia in early trial
Disease control Not yet recruitingThis study tests a new treatment for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to better find and attack leukemia cells. The goal is to see if this therapy can safe…
Phase: PHASE1, PHASE2 • Sponsor: Xuzhou Medical University • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New PET tracer lets doctors watch Cancer-Fighting cells in real time
Knowledge-focused Not yet recruitingThis early-stage study tests a new PET imaging agent called 68Ga-NOTA-BCMA to track CAR-T cells in people with multiple myeloma. Ten participants will receive the tracer before their scheduled CAR-T therapy, and doctors will use PET scans to see where the cells go in the body. Th…
Phase: EARLY_PHASE1 • Sponsor: Xuzhou Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 11:59 UTC